|
|
Exchange: |
OTC Bulletin Board |
Security
Type: |
Common |
Shares
Out: |
29,950,000 |
Market
Cap: |
92.85(M) |
Last
Volume: |
42,300 |
Avg
Vol: |
42,181 |
52
Week Range: |
$2.85 - $5.97 |
|
Level
I Sector: |
Information Technology |
Level
II Sector: |
Computer Hardware |
Level
III Sector: |
Computer Peripherals |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : 9.1 |
Insider 6 Months : 9.1 |
Insider 3/6 Months : 18.2 |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Anixa Biosciences is a biotechnology company developing therapies and vaccines that are focused on unmet needs in oncology and infectious disease. Co.'s therapeutics programs include the development of a chimeric endocrine receptor T-cell therapy, a form of chimeric antigen receptor T-cell technology, initially focused on treating ovarian cancer and the discovery and development of anti-viral drug candidates for the treatment of Coronavirus disease 2019 focused on inhibiting certain protein functions of the virus. Co.'s vaccine programs include the development of a vaccine against triple negative breast cancer as well other forms of breast cancer and a vaccine against ovarian cancer.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
55,009 |
55,009 |
60,509 |
78,518 |
Total Buy Value |
$182,130 |
$182,130 |
$202,150 |
$251,028 |
Total People Bought |
3 |
3 |
4 |
4 |
Total Buy Transactions |
3 |
3 |
4 |
7 |
Total Shares Sold |
0 |
0 |
11,800 |
11,800 |
Total Sell Value |
$0 |
$0 |
$42,126 |
$42,126 |
Total People Sold |
0 |
0 |
1 |
1 |
Total Sell Transactions |
0 |
0 |
1 |
1 |
End Date |
2024-01-18 |
2023-10-17 |
2023-04-18 |
2022-04-18 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Titterton Lewis H Jr |
Director |
|
2021-07-26 |
4 |
B |
$4.21 |
$126,300 |
D/D |
30,000 |
935,826 |
2.39 |
-21% |
|
Baskies Arnold M |
Director |
|
2021-07-23 |
4 |
B |
$4.33 |
$82,270 |
D/D |
19,000 |
100,000 |
2.39 |
-14% |
|
Kumar Amit |
Chief Executive Officer |
|
2021-07-23 |
4 |
B |
$4.28 |
$21,400 |
D/D |
5,000 |
292,000 |
2.81 |
-14% |
|
Titterton Lewis H Jr |
Director |
|
2021-07-16 |
4 |
B |
$4.07 |
$40,700 |
D/D |
10,000 |
905,826 |
2.39 |
-1% |
|
Titterton Lewis H Jr |
Director |
|
2021-07-15 |
4 |
B |
$3.65 |
$8,030 |
D/D |
2,200 |
895,826 |
2.39 |
1% |
|
Baskies Arnold M |
Director |
|
2021-07-15 |
4 |
B |
$3.90 |
$78,000 |
D/D |
20,000 |
81,000 |
2.39 |
1% |
|
Gottschalk Emily |
Director |
|
2021-07-15 |
4 |
B |
$3.96 |
$79,457 |
D/D |
20,065 |
45,665 |
2.39 |
1% |
|
Titterton Lewis H Jr |
Director |
|
2021-07-14 |
4 |
B |
$3.72 |
$86,676 |
D/D |
23,300 |
893,626 |
2.39 |
5% |
|
Catelani Michael |
COO & CFO |
|
2021-04-30 |
4 |
A |
$1.84 |
$3,007 |
D/D |
1,634 |
9,383 |
|
- |
|
Gottschalk Emily |
Director |
|
2021-04-23 |
4 |
B |
$4.49 |
$44,900 |
D/D |
10,000 |
25,600 |
2.39 |
13% |
|
Baskies Arnold M |
Director |
|
2021-04-20 |
4 |
B |
$3.91 |
$39,100 |
D/D |
10,000 |
61,000 |
2.39 |
26% |
|
Titterton Lewis H Jr |
Director |
|
2021-04-19 |
4 |
B |
$3.99 |
$19,950 |
D/D |
5,000 |
870,326 |
2.39 |
21% |
|
Titterton Lewis H Jr |
Director |
|
2021-03-25 |
4 |
B |
$4.84 |
$217,800 |
D/D |
45,000 |
865,326 |
2.39 |
-12% |
|
Gottschalk Emily |
Director |
|
2021-03-25 |
4 |
B |
$4.88 |
$76,128 |
D/D |
15,600 |
15,600 |
2.39 |
-12% |
|
Baskies Arnold M |
Director |
|
2021-03-25 |
4 |
B |
$4.80 |
$48,000 |
D/D |
10,000 |
51,000 |
2.39 |
-12% |
|
Kumar Amit |
Chief Executive Officer |
|
2021-03-25 |
4 |
B |
$4.86 |
$24,300 |
D/D |
5,000 |
277,000 |
2.81 |
-12% |
|
Titterton Lewis H Jr |
Director |
|
2021-02-03 |
4 |
GD |
$0.00 |
$0 |
D/D |
200,000 |
820,326 |
|
- |
|
Kumar Amit |
Chief Executive Officer |
|
2021-01-29 |
4 |
B |
$3.73 |
$37,300 |
D/D |
10,000 |
272,000 |
2.81 |
19% |
|
Catelani Michael |
COO & CFO |
|
2020-10-31 |
4 |
A |
$1.56 |
$2,992 |
D/D |
1,918 |
7,749 |
|
- |
|
Titterton Lewis H Jr |
Director |
|
2020-09-11 |
4 |
B |
$2.08 |
$83,200 |
D/D |
40,000 |
1,020,326 |
2.39 |
103% |
|
Kumar Amit |
Chief Executive Officer |
|
2020-09-11 |
4 |
B |
$2.11 |
$59,080 |
D/D |
28,000 |
262,000 |
2.81 |
103% |
|
Titterton Lewis H Jr |
Director |
|
2020-06-16 |
4 |
B |
$2.27 |
$55,615 |
D/D |
24,500 |
980,326 |
2.39 |
-14% |
|
Titterton Lewis H Jr |
Director |
|
2020-06-15 |
4 |
B |
$2.27 |
$70,558 |
D/D |
31,083 |
955,826 |
2.39 |
-1% |
|
Kumar Amit |
Chief Executive Officer |
|
2020-06-12 |
4 |
B |
$2.03 |
$40,600 |
D/D |
20,000 |
234,000 |
2.81 |
-0% |
|
Catelani Michael |
COO & CFO |
|
2020-04-30 |
4 |
A |
$1.61 |
$3,006 |
D/D |
1,867 |
5,829 |
|
- |
|
36 Records found
|
|
Page 1 of 2 |
|
|